Hepatitis A and typhoid vaccine is a combination vaccine to protect against the infectious diseases hepatitis A and typhoid. It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria. Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3][4][5][6][7] and ViATIM[8] from Sanofi Pasteur.[1][9]
Society and culture
Brand names
The vaccine is distributed under various brand names in the European Union.[1]
References
- List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed) European Medicines Agency (EMA), retrieved 18 October 2020^
- Hepatyrix. Package Leaflet:Information for the user Drugs.com, retrieved 15 July 2018^
- VIVAXIM suspension and solution for suspension for injection in pre-filled syringe Drugs.com, retrieved 15 July 2018^
- Australian Product Information – Vivaxim (Salmonella typhi Vi polysaccharide and hepatitis A virus antigen) Vaccine retrieved 18 October 2020^
- Vivaxim Salmonella typhi vaccine; Hepatitis A vaccine 5 March 2020, retrieved 18 October 2020^
- Vivaxim 1mL injection syringe composite pack Therapeutic Goods Administration (TGA), retrieved 18 October 2020^
- Summary for ARTG Entry: 82745 Vivaxim 1mL injection syringe composite pack Therapeutic Goods Administration (TGA), retrieved 18 October 2020^
- ViATIM suspension and solution for suspension for injection in pre-filled syringe Drugs.com, retrieved 15 July 2018^
- ViATIM suspension and solution for suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) (emc), 3 September 2019, retrieved 18 October 2020^